Jaguar Health (JAGX) Prepaid Assets (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Prepaid Assets of $2.0 million for Q1 2026, down 84.01% year-over-year from $12.8 million in Q1 2025, and down 7.63% quarter-over-quarter from $2.2 million in Q4 2025.
Jaguar Health (JAGX) Prepaid Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Prepaid Assets for 13 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 84.01% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 84.01% YoY), while the FY2025 annual figure was $2.2 million, down 81.84% from the prior year.
- Prepaid Assets slipped to $2.0 million in Q1 2026 per JAGX's latest filing, from $2.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $13.7 million in Q3 2025 and bottomed at $2.0 million in Q1 2026.
- Historically, Prepaid Assets has averaged $9.0 million across 5 years, with a median of $9.8 million in 2023.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 102.52% — and 2026, when it tumbled 84.01%.
- Jaguar Health's Prepaid Assets stood at $7.4 million in 2022, then soared by 37.49% to $10.1 million in 2023, then gained by 20.58% to $12.2 million in 2024, then sank by 81.84% to $2.2 million in 2025, then dropped by 7.63% to $2.0 million in 2026.
- Business Quant data shows JAGX's Prepaid Assets at $2.0 million in Q1 2026, $2.2 million in Q4 2025, and $13.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | 13.74 Mn |
| Jun 30, 2025 | 13.66 Mn |
| Mar 31, 2025 | 12.81 Mn |
| Dec 31, 2024 | 12.20 Mn |
| Sep 30, 2024 | 12.39 Mn |
| Jun 30, 2024 | 13.14 Mn |
| Mar 31, 2024 | 11.31 Mn |
| Dec 31, 2023 | 10.12 Mn |
| Sep 30, 2023 | 8.61 Mn |
| Jun 30, 2023 | 9.78 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 7.36 Mn |
| Sep 30, 2022 | 5.59 Mn |
| Jun 30, 2022 | 5.53 Mn |
| Mar 31, 2022 | 3.88 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 4.91 Mn |
| Jun 30, 2021 | 4.81 Mn |